ADH1B promotes mesothelial clearance and ovarian cancer infiltration

Primary debulking surgery followed by adjuvant chemotherapy is the standard treatment for ovarian cancer. Residual disease after primary surgery is associated with poor patient outcome. Previously, we discovered ADH1B to be a molecular biomarker of residual disease. In the current study, we investig...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Oncotarget 2018-05, Vol.9 (38), p.25115-25126
Hauptverfasser:	Gharpure, Kshipra M, Lara, Olivia D, Wen, Yunfei, Pradeep, Sunila, LaFargue, Chris, Ivan, Cristina, Rupaimoole, Rajesha, Hu, Wei, Mangala, Lingegowda S, Wu, Sherry Y, Nagaraja, Archana S, Baggerly, Keith, Sood, Anil K
Format:	Artikel
Sprache:	eng
Schlagworte:	Research Paper
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!